Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Some information in this page has been claimed confidential.
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2003-04-15 to 2003-06-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21. July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Test material form:
- other: paste
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other: Histidin auxotroph
- Species / strain / cell type:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix (fraction of Spraque Dawley rat liver incuded with Aroclor 1254). Obtained by Molecular Toxicology, Inc., 157 Industrial Park Dr. Boone, NC 28607, USA.
- Test concentrations with justification for top dose:
- First plate incorporation test serving as range finding test: with metabolic activation (10 % S9 liver homogenate): 50, 160, 500, 1600, 5000 µg/plate
without metabolic activation: 50, 160, 500, 1600, 5000 µg/plate
Second plate incorporation test: with metabolic activation (10 % S9 rat liver homogenate): 1.6, 5, 16, 50, 160, 500 µg/plate (TA 1537), and 5, 16, 50, 160, 500, 1600 µg/plate (TA 100, TA 1535, TA 98, WP2uvrA),
without metabolic activation: 0.5, 1.6, 5, 16, 50, 160 µg/plate (TA 100, TA 1537), 1.6, 5, 16, 50, 160, 500 µg/plate (TA 1535, TA 98) and 16, 50, 160, 500, 1600, 5000 µg/plate (WP2uvrA)
Third plate incorporation test: with metabolic activation (30 % S9 rat liver homogenate): 1.6, 5, 16, 50, 160, 500 µg/plate (TA 1537), and 5, 16, 50, 160, 500, 1600 µg/plate (TA 100, TA 1535, TA 98, WP2uvrA)
without metabolic activation: 0.5, 1.6, 5, 16, 50, 160 µg/plate (TA 100, TA 1537), and 1.6, 5, 16, 50, 160, 500 µg/plate (TA 1535, TA 98), and 5, 16, 50, 160, 500, 1600 µg/plate (WP2uvrA)
Repeat of third plate incorporation test: with metabolic activation (30 % S9 rat liver homogenat): 50, 160, 500, 1600, 5000 µg/plate (TA 100, WP2uvrA)
without metabolic activation: 50, 160, 500, 1600, 5000 µg/plate (WP2uvrA) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Justification for choice of solvent/vehicle: Other common vehicles (deionizede water, DMSO) were not appropriate due to insolubility of the test item. Stability and homogeneity (to be reached by stirring) of the test item in the vehicle is guaranteed by the sponsor (Report Ulrike Reploeg, dated 31-Mar-2003) for 4 hours.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene for all strains; with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) with 10 and 30 % S9-mix in the third assay.
DURATION
- Preincubation period: not done
- Exposure duration: 48 h
NUMBER OF PLATES EVALUATED: three per dose
NUMBER OF REPLICATIONS: Three independent experiments were performed
DETERMINATION OF CYTOTOXICITY
- Method: toxicity to bacteria was assessed by thinning of the bacterial lawns and/or reduction in the number of colonies.
- Evaluation criteria:
- Criteria for a valid assay
The assay is considered valid if the following criteria are met:
- the solvent control data are within the laboratory's normal control range for the spontaneous mutant frequency
- the positive controls induce increases in the mutation frequency which are significant and within the laboratory's normal range
Criteria for a positive response
A test compound is classified as mutagenic if it has either of the following effects:
a) it produces at least a 2-fold increase in the mean number of revertants per plate of at least one of the tester strains over the mean number of revertants per plate of the appropriate vehicle control at complete bacterial background lawn
b) it induces a dose-related increase in the mean number of revertants per plate of at least one of the tester strains over the mean number of revertants per plate of the appropriate vehicle control in at least two to three concentrations of the test compound at complete bacterial background lawn. If the test substance does not achieve either of the above criteria, it is considered to show no evidence of mutagenic activity in this system. - Statistics:
- No
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Solubility: The test item was dissolved in ethanol and a stock solution of 50 mg/ml was prepared for the highest concentration, which provided a final concentration of 5000 µg/plate. Further dilutions of 1600, 500, 160, 50, 16, 5, 1.6 and 0.5 µg/plate were used in the different experiments
- Precipitation: visible precipitation of Praepagen TQ on the plates was observed at 1600 µg/plate and above.
RANGE-FINDING/SCREENING STUDIES:
In the first plate incorporation test with 10 % S9-mix bacteria were treated with doses of 50, 160, 500, 1600 and 5000 µg/plate. Howeever the test item was toxic to all bacteria strains so that evaluation according to the guidelines (5 doses) was not possible. This test served therefore only as range finding test.
COMPARISON WITH HISTORICAL CONTROL DATA:
Values were within the laboratory´s historical control range. Only the number of revertant colonies of the solvent controls in strains TA 1537 and WP2 were slightly out of the historical control data range with ethanol in some experiments. However, the existing control data pool with ethanol is limited as this solvent is used rarely. The historical control data pool for DMSO indicating that all values are in normal range and do not influence the validity of the study.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Doses in the second plate incorporation test with 10 % S9-mix based on the toxicity to bacteria observed in the first test. In this test toxicity to bacteria in form of incomplete bacterial lawn was observed without metabolic activation at dose levels of 160 µg/plate and above with the strains TA 100, TA 1535, TA 1537 and TA 98 and at dose levels of 500 µg/plate and above with the strain WP2uvrA. In the presence of metabolic activation the test compound proved to be toxic to bacterial strains TA 100, TA 1537 and TA 98 at concentrations of 500 µg/plate and above and at a concentration of 1600 µg/plate to bacterial strains TA 1535 and WP2uvrA.
The top dose level for the third plate incorporation test (30 % S9-mix) was selected on the basis of toxicity to bacteria observed in previous tests. In the third plate incorporation test (with 30% rat liver homogenate) toxicity was observed without metabolic activation at dose levels of 160 µg/plate andabove with the tester strains TA 100, TA 1535, TA 1537 and TA 98. In the presence of metabolic activation the test compound proved to be toxic to the tester strain TA 1537 at a concentration of 500 µg/plate and at a concentration of 1600 µg/plate to bacterial strains TA 1535 and TA 98.
30 % S9-mix reduced toxicity to E. coli WP2 and TA 100 in the third test with the result that the maximum dose showed no toxicity to bacteria as required by the guideline. Therefore, the test with 30 % 89 had to be repeated with this strains (repeat plate incorporation test) using doses up to 5000 µg/plate, In the repeat test with 30 % rat liver homogenate toxicity to bacteria in form of incomplete bacteria lawn was observed with strain TA 100 (+ S9-mix) at a dose level of 1600 µg/plate and with E. coli WP2 at a dose level of 1600 µg/plate and above (-S9-mix).
Slight differences in toxicity to bacteria in the experiments with 30 % S9-mix (WP2 -S9-mix) are probably caused by biological variability.
Any other information on results incl. tables
Sterility control:
The plates for sterility control of test item and S9-mix showed no growth.
Applicant's summary and conclusion
- Conclusions:
- There was no evidence of induced mutant colonies over background in any of the tester strains in the presence or absence of mammalian metabolic activation in this study.
- Executive summary:
In a reverse gene mutation assay in bacteria according to OECD guideline 471, 1997, strains TA1535, TA 1537, TA 98 and TA 100 of S. typhimurium and E. coli WP2 were exposed to partially unsaturated TEA-Esterquat. Three independent experiments were performed up to the limit concentration of 5000 µg/plate with and without mammalian metabolic activation (rat liver S9-mix 10 and 30 %).
Significant bacteriotoxic effects of varying severeness were observed, depending on the test strain and the presence of metabolic activation. Generally, bacteriotoxicity was less pronounced in the presence of metabolic activation, especially at concentrations of 30 % S9-mix. Precipitation was observed at 1600 µg/plate and above. There was no evidence of induced mutant colonies over background in any of the tester strains in the presence or absence of mammalian metabolic activation.
The positive controls induced the appropriate responses in the corresponding strains and activity of metabolizing system was confirmed.
There was no evidence of induced mutant colonies over background.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies